Header Logo

Connection

TETSUO ASHIZAWA to Adult

Back to Details
This is a "connection" page, showing publications TETSUO ASHIZAWA has written about Adult.
TETSUO ASHIZAWA
Connection Strength
0.990
Adult
  1. Analysis of diffusion tensor parameters in spinocerebellar ataxia type 3 and type 10 patients. Parkinsonism Relat Disord. 2020 09; 78:73-78.
    View in: PubMed
    Score: 0.038
  2. Cancer frequency in patients with spinocerebellar ataxia type 10. Parkinsonism Relat Disord. 2020 07; 76:1-2.
    View in: PubMed
    Score: 0.038
  3. Clinical and Genetic Evaluation of Spinocerebellar Ataxia Type 10 in 16 Brazilian Families. Cerebellum. 2019 Oct; 18(5):849-854.
    View in: PubMed
    Score: 0.036
  4. Spinocerebellar ataxias in Southern Brazil: Genotypic and phenotypic evaluation of 213 families. Clin Neurol Neurosurg. 2019 Sep; 184:105427.
    View in: PubMed
    Score: 0.036
  5. SPG7 and Impaired Emotional Communication. Cerebellum. 2017 04; 16(2):595-598.
    View in: PubMed
    Score: 0.031
  6. SMRT Sequencing of Long Tandem Nucleotide Repeats in SCA10 Reveals Unique Insight of Repeat Expansion Structure. PLoS One. 2015; 10(8):e0135906.
    View in: PubMed
    Score: 0.027
  7. Clinical characteristics of patients with spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis. 2013 Nov 13; 8:177.
    View in: PubMed
    Score: 0.024
  8. Spinocerebellar ataxia type 10: from Amerindians to Latin Americans. Curr Neurol Neurosci Rep. 2013 Nov; 13(11):393.
    View in: PubMed
    Score: 0.024
  9. Purkinje cell loss is the major brain pathology of spinocerebellar ataxia type 10. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1409-11.
    View in: PubMed
    Score: 0.024
  10. Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro. J Mol Neurosci. 2013 Oct; 51(2):237-48.
    View in: PubMed
    Score: 0.023
  11. Ethnic origin and extrapyramidal signs in an Argentinean spinocerebellar ataxia type 10 family. Neurology. 2007 Jul 10; 69(2):216-8.
    View in: PubMed
    Score: 0.016
  12. Prevalence, Severity, and Progression of Cerebellar Cognitive-Affective Syndrome in Patients With Spinocerebellar Ataxias. Neurology. 2025 Sep 09; 105(5):e213980.
    View in: PubMed
    Score: 0.014
  13. Fixel-Based Analysis of Diffusion Imaging as a Quantitative Marker of Disease State in Spinocerebellar Ataxia. Ann Clin Transl Neurol. 2025 Sep; 12(9):1846-1857.
    View in: PubMed
    Score: 0.014
  14. Suicidal Ideation in Spinocerebellar Ataxia. J Neuropsychiatry Clin Neurosci. 2026; 38(1):38-44.
    View in: PubMed
    Score: 0.013
  15. The impact of interrupted ATXN10 expansions on clinical findings of spinocerebellar ataxia type 10. J Neurol. 2025 Mar 11; 272(4):261.
    View in: PubMed
    Score: 0.013
  16. Spinocerebellar Ataxia Progression Measured with the Patient-Reported Outcome Measure of Ataxia. Mov Disord. 2025 May; 40(5):917-927.
    View in: PubMed
    Score: 0.013
  17. ATXN10 Gene Expansions in Mexican Patients with Ataxia Without Epilepsy. Cerebellum. 2025 Jan 16; 24(2):33.
    View in: PubMed
    Score: 0.013
  18. Sensitivity of Advanced Magnetic Resonance Imaging to Progression over Six?Months in Early Spinocerebellar Ataxia. Mov Disord. 2024 Oct; 39(10):1856-1867.
    View in: PubMed
    Score: 0.013
  19. SARA captures disparate progression and responsiveness in spinocerebellar ataxias. J Neurol. 2024 Jul; 271(7):3743-3753.
    View in: PubMed
    Score: 0.013
  20. Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Mov Disord Clin Pract. 2024 May; 11(5):496-503.
    View in: PubMed
    Score: 0.012
  21. The Cerebellar Cognitive Affective/Schmahmann Syndrome Scale in Spinocerebellar Ataxias. Cerebellum. 2024 Aug; 23(4):1411-1425.
    View in: PubMed
    Score: 0.012
  22. Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial. Lancet Neurol. 2023 03; 22(3):218-228.
    View in: PubMed
    Score: 0.011
  23. Clinical features and ATTCT repeat expansion in spinocerebellar ataxia type 10. Arch Neurol. 2002 Aug; 59(8):1285-90.
    View in: PubMed
    Score: 0.011
  24. Brief assessment of cognitive function in myotonic dystrophy: Multicenter longitudinal study using computer-assisted evaluation. Muscle Nerve. 2022 05; 65(5):560-567.
    View in: PubMed
    Score: 0.011
  25. Alcohol dehydrogenase polymorphism and Parkinson's disease. Neurosci Lett. 2001 Jun 01; 305(1):70-2.
    View in: PubMed
    Score: 0.010
  26. Clinical and genomic analysis of a large Chinese family with familial cortical myoclonic tremor with epilepsy and SAMD12 intronic repeat expansion. Epilepsia Open. 2021 03; 6(1):102-111.
    View in: PubMed
    Score: 0.010
  27. A "dystrophic" variant of autosomal recessive myotonia congenita caused by novel mutations in the CLCN1 gene. Neurology. 2000 Dec 12; 55(11):1697-703.
    View in: PubMed
    Score: 0.010
  28. Balance and physical functioning in Spinocerebellar ataxias 3 and 10. Acta Neurol Scand. 2021 Apr; 143(4):458-463.
    View in: PubMed
    Score: 0.010
  29. Primary coenzyme Q10 deficiency due to COQ8A gene mutations. Mol Genet Genomic Med. 2020 10; 8(10):e1420.
    View in: PubMed
    Score: 0.010
  30. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology. 2000 Mar 14; 54(5):1195-8.
    View in: PubMed
    Score: 0.009
  31. Pulse-Field capillary electrophoresis of repeat-primed PCR amplicons for analysis of large repeats in Spinocerebellar Ataxia Type 10. PLoS One. 2020; 15(3):e0228789.
    View in: PubMed
    Score: 0.009
  32. The impact of ethnicity on the clinical presentations of spinocerebellar ataxia type 3. Parkinsonism Relat Disord. 2020 03; 72:37-43.
    View in: PubMed
    Score: 0.009
  33. Tremor in the Degenerative Cerebellum: Towards the Understanding of Brain Circuitry for Tremor. Cerebellum. 2019 Jun; 18(3):519-526.
    View in: PubMed
    Score: 0.009
  34. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol. 1998 Dec; 55(12):1521-3.
    View in: PubMed
    Score: 0.009
  35. Polymorphisms in DNA methylation-related genes are linked to the phenotype of Machado-Joseph disease. Neurobiol Aging. 2019 03; 75:225.e1-225.e8.
    View in: PubMed
    Score: 0.009
  36. Body composition in Spinocerebellar ataxia type 3 and 10 patients: Comparative study with control group. Nutr Neurosci. 2020 Jan; 23(1):49-54.
    View in: PubMed
    Score: 0.008
  37. Spinocerebellar ataxias type 3 and 10: Onset and progression of ataxia during pregnancy and puerperium. Parkinsonism Relat Disord. 2018 07; 52:119-120.
    View in: PubMed
    Score: 0.008
  38. Instability of the (CTG)n repeat in congenital myotonic dystrophy. Am J Hum Genet. 1997 Dec; 61(6):1445-8.
    View in: PubMed
    Score: 0.008
  39. C9orf72 repeat expansions as genetic modifiers for depression in spinocerebellar ataxias. Mov Disord. 2018 03; 33(3):497-498.
    View in: PubMed
    Score: 0.008
  40. Dystonia and ataxia progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2017 Dec; 45:75-80.
    View in: PubMed
    Score: 0.008
  41. Postural Tremor and Ataxia Progression in Spinocerebellar Ataxias. Tremor Other Hyperkinet Mov (N Y). 2017; 7:492.
    View in: PubMed
    Score: 0.008
  42. The Initial Symptom and Motor Progression in Spinocerebellar Ataxias. Cerebellum. 2017 06; 16(3):615-622.
    View in: PubMed
    Score: 0.008
  43. Ubiquitin-related network underlain by (CAG)n loci modulate age at onset in Machado-Joseph disease. Brain. 2017 04 01; 140(4):e25.
    View in: PubMed
    Score: 0.008
  44. [A case report of volatile solvent psychosis]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1996 Oct; 31(5):475-82.
    View in: PubMed
    Score: 0.007
  45. ATXN2-AS, a gene antisense to ATXN2, is associated with spinocerebellar ataxia type 2 and amyotrophic lateral sclerosis. Ann Neurol. 2016 10; 80(4):600-15.
    View in: PubMed
    Score: 0.007
  46. Cervical dystonia as the initial presentation of Huntington's disease. Mov Disord. 1996 Jul; 11(4):457-9.
    View in: PubMed
    Score: 0.007
  47. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression. Cerebellum. 2015 Dec; 14(6):677-81.
    View in: PubMed
    Score: 0.007
  48. Depression and clinical progression in spinocerebellar ataxias. Parkinsonism Relat Disord. 2016 Jan; 22:87-92.
    View in: PubMed
    Score: 0.007
  49. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease. J Med Genet. 1995 Jul; 32(7):516-8.
    View in: PubMed
    Score: 0.007
  50. Analysis of the GGGGCC Repeat Expansions of the C9orf72 Gene in SCA3/MJD Patients from China. PLoS One. 2015; 10(6):e0130336.
    View in: PubMed
    Score: 0.007
  51. De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet. 1995 May; 56(5):1067-74.
    View in: PubMed
    Score: 0.007
  52. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuroophthalmol. 2015 Mar; 35(1):16-21.
    View in: PubMed
    Score: 0.007
  53. Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients. PLoS One. 2015; 10(2):e0117488.
    View in: PubMed
    Score: 0.007
  54. Tourettism associated with Huntington's disease. Mov Disord. 1995 Jan; 10(1):103-5.
    View in: PubMed
    Score: 0.007
  55. Coenzyme Q10 and spinocerebellar ataxias. Mov Disord. 2015 Feb; 30(2):214-20.
    View in: PubMed
    Score: 0.006
  56. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain. 2014 Sep; 137(Pt 9):2444-55.
    View in: PubMed
    Score: 0.006
  57. Spinocerebellar ataxia type 10 in Peru: the missing link in the Amerindian origin of the disease. J Neurol. 2014 Sep; 261(9):1691-4.
    View in: PubMed
    Score: 0.006
  58. CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994 Jun; 44(6):1137-43.
    View in: PubMed
    Score: 0.006
  59. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet. 1994 Mar; 54(3):414-23.
    View in: PubMed
    Score: 0.006
  60. Effects of the sex of myotonic dystrophy patients on the unstable triplet repeat in their affected offspring. Neurology. 1994 Jan; 44(1):120-2.
    View in: PubMed
    Score: 0.006
  61. Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures. Neurogenetics. 2014 Mar; 15(1):59-64.
    View in: PubMed
    Score: 0.006
  62. Comprehensive phenotype of the p.Arg420his allelic form of spinocerebellar ataxia type 13. Cerebellum. 2013 Dec; 12(6):932-6.
    View in: PubMed
    Score: 0.006
  63. Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies. Neuromuscul Disord. 2014 Mar; 24(3):227-40.
    View in: PubMed
    Score: 0.006
  64. Mutation in the kv3.3 voltage-gated potassium channel causing spinocerebellar ataxia 13 disrupts sound-localization mechanisms. PLoS One. 2013; 8(10):e76749.
    View in: PubMed
    Score: 0.006
  65. Diagnostic odyssey of patients with myotonic dystrophy. J Neurol. 2013 Oct; 260(10):2497-504.
    View in: PubMed
    Score: 0.006
  66. Analysis of the visual system in Friedreich ataxia. J Neurol. 2013 Sep; 260(9):2362-9.
    View in: PubMed
    Score: 0.006
  67. Using next-generation sequencing as a genetic diagnostic tool in rare autosomal recessive neurologic Mendelian disorders. Neurobiol Aging. 2013 Oct; 34(10):2442.e11-7.
    View in: PubMed
    Score: 0.006
  68. Acute onset of cerebellar ataxia in a spinocerebellar ataxia type 10 patient after use of steroids. Arq Neuropsiquiatr. 2013 Jan; 71(1):66.
    View in: PubMed
    Score: 0.006
  69. Profile of the regions on the alpha-chain of human acetylcholine receptor recognized by autoantibodies in myasthenia gravis. Mol Immunol. 1992 Dec; 29(12):1507-14.
    View in: PubMed
    Score: 0.006
  70. Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology. 1992 Oct; 42(10):1871-7.
    View in: PubMed
    Score: 0.006
  71. Affective communication deficits associated with cerebellar degeneration. Neurocase. 2014; 20(1):18-26.
    View in: PubMed
    Score: 0.006
  72. Phenotypic expression of the myotonic dystrophy gene in monozygotic twins. Neurology. 1992 Sep; 42(9):1815-7.
    View in: PubMed
    Score: 0.006
  73. Population stratification may bias analysis of PGC-1a as a modifier of age at Huntington disease motor onset. Hum Genet. 2012 Dec; 131(12):1833-40.
    View in: PubMed
    Score: 0.006
  74. Olfactory impairment in familial ataxias. J Neurol Neurosurg Psychiatry. 2012 Oct; 83(10):970-4.
    View in: PubMed
    Score: 0.005
  75. TAA repeat variation in the GRIK2 gene does not influence age at onset in Huntington's disease. Biochem Biophys Res Commun. 2012 Aug 03; 424(3):404-8.
    View in: PubMed
    Score: 0.005
  76. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology. 2012 Mar 06; 78(10):690-5.
    View in: PubMed
    Score: 0.005
  77. Diagnostic value of ophthalmologic findings in myotonic dystrophy: comparison with risks calculated by haplotype analysis of closely linked restriction fragment length polymorphisms. Am J Med Genet. 1992 Jan 01; 42(1):55-60.
    View in: PubMed
    Score: 0.005
  78. Spinocerebellar ataxia type 10: disproportionate cerebellar symptoms among at-risk subjects induced by small amounts of alcohol. Arq Neuropsiquiatr. 2011 Oct; 69(5):841.
    View in: PubMed
    Score: 0.005
  79. Confirmation of the severe phenotypic effect of serine at codon 41 of the superoxide dismutase 1 gene. Muscle Nerve. 2011 Oct; 44(4):499-502.
    View in: PubMed
    Score: 0.005
  80. Symptom onset of spinocerebellar ataxia type 10 in pregnancy and puerperium. J Clin Neurosci. 2011 Mar; 18(3):437-8.
    View in: PubMed
    Score: 0.005
  81. Spinocerebellar ataxia type 10: Frequency of epilepsy in a large sample of Brazilian patients. Mov Disord. 2010 Dec 15; 25(16):2875-8.
    View in: PubMed
    Score: 0.005
  82. Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
    View in: PubMed
    Score: 0.005
  83. Health related quality of life measures in Friedreich Ataxia. J Neurol Sci. 2008 Sep 15; 272(1-2):123-8.
    View in: PubMed
    Score: 0.004
  84. Clinical and molecular diagnosis of a Costa Rican family with autosomal recessive myotonia congenita (Becker disease) carrying a new mutation in the CLCN1 gene. Rev Biol Trop. 2008 Mar; 56(1):1-11.
    View in: PubMed
    Score: 0.004
  85. Instability of expanded CAG/CAA repeats in spinocerebellar ataxia type 17. Eur J Hum Genet. 2008 Feb; 16(2):215-22.
    View in: PubMed
    Score: 0.004
  86. Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008 Apr 15; 267(1-2):174-6.
    View in: PubMed
    Score: 0.004
  87. Anticipation and intergenerational repeat instability in spinocerebellar ataxia type 17. Ann Neurol. 2007 Jun; 61(6):607-10.
    View in: PubMed
    Score: 0.004
  88. Reduced penetrance in a Brazilian family with spinocerebellar ataxia type 10. Arch Neurol. 2007 Apr; 64(4):591-4.
    View in: PubMed
    Score: 0.004
  89. Genome-wide significance for a modifier of age at neurological onset in Huntington's disease at 6q23-24: the HD MAPS study. BMC Med Genet. 2006 Aug 17; 7:71.
    View in: PubMed
    Score: 0.004
  90. Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA. 2006 Aug 09; 296(6):661-70.
    View in: PubMed
    Score: 0.004
  91. Measuring Friedreich ataxia: complementary features of examination and performance measures. Neurology. 2006 Jun 13; 66(11):1711-6.
    View in: PubMed
    Score: 0.004
  92. False positive anti-acetylcholine receptor antibodies in motorneurone disease. Lancet. 1986 May 31; 1(8492):1272.
    View in: PubMed
    Score: 0.004
  93. Complement-dependent lysis of cultured rat myotubes by myasthenic immunoglobulins. Neurology. 1985 Dec; 35(12):1748-53.
    View in: PubMed
    Score: 0.003
  94. The hot bath test in multiple sclerosis: comparison with visual evoked responses and oligoclonal bands. Acta Neurol Scand. 1985 Jul; 72(1):65-7.
    View in: PubMed
    Score: 0.003
  95. Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale. Neurology. 2005 Apr 12; 64(7):1261-2.
    View in: PubMed
    Score: 0.003
  96. A rare truncating mutation in ADH1C (G78Stop) shows significant association with Parkinson disease in a large international sample. Arch Neurol. 2005 Jan; 62(1):74-8.
    View in: PubMed
    Score: 0.003
  97. Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology. 2004 Dec 28; 63(12):2280-7.
    View in: PubMed
    Score: 0.003
  98. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004 Nov; 56(5):670-4.
    View in: PubMed
    Score: 0.003
  99. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology. 2004 Oct 26; 63(8):1509-12.
    View in: PubMed
    Score: 0.003
  100. Minocycline in Huntington's disease: a pilot study. Mov Disord. 2004 Jun; 19(6):692-5.
    View in: PubMed
    Score: 0.003
  101. Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects. Neurology. 2004 Jan 27; 62(2):269-74.
    View in: PubMed
    Score: 0.003
  102. [Significance of time-lapse changes in gallium-67 citrate accumulation in the diagnosis of hepatoma]. Kaku Igaku. 1983 Dec; 20(10):1449-58.
    View in: PubMed
    Score: 0.003
  103. Huntington's disease--like 2 can present as chorea-acanthocytosis. Neurology. 2003 Oct 14; 61(7):1002-4.
    View in: PubMed
    Score: 0.003
  104. A dominantly inherited syndrome with continuous motor neuron discharges. Ann Neurol. 1983 Mar; 13(3):285-90.
    View in: PubMed
    Score: 0.003
  105. [CT images of diffuse hepatic disease]. Rinsho Hoshasen. 1982 Dec; 27(13):1411-6.
    View in: PubMed
    Score: 0.003
  106. Instability of a premutation allele in homozygous patients with myotonic dystrophy type 1. Ann Neurol. 2002 Oct; 52(4):435-41.
    View in: PubMed
    Score: 0.003
  107. Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson's disease. Neurology. 2002 Mar 26; 58(6):881-4.
    View in: PubMed
    Score: 0.003
  108. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol. 2001 Aug; 50(2):234-9.
    View in: PubMed
    Score: 0.003
  109. Paroxysmal kinesigenic dyskinesia and infantile convulsions: clinical and linkage studies. Neurology. 2000 Jul 25; 55(2):224-30.
    View in: PubMed
    Score: 0.002
  110. [Prediction of the clinical efficacy of hepatic arterial chemotherapy for metastatic hepatic cancer by intraarterial infusion of 99mTc-MIBI]. Kaku Igaku. 2000 Jan; 37(1):29-33.
    View in: PubMed
    Score: 0.002
  111. [Nurses' knowledge of alcohol-related problems and their treatment: a comparison of nurses in general hospital and alcoholism treatment units]. Nihon Arukoru Yakubutsu Igakkai Zasshi. 1998 Dec; 33(6):671-82.
    View in: PubMed
    Score: 0.002
  112. Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology. 1998 Oct; 51(4):1081-6.
    View in: PubMed
    Score: 0.002
  113. Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet. 1997 May; 60(5):1251-6.
    View in: PubMed
    Score: 0.002
  114. Myotonic dystrophy phenotype without expansion of (CTG)n repeat: an entity distinct from proximal myotonic myopathy (PROMM)? J Neurol. 1996 Oct; 243(10):715-21.
    View in: PubMed
    Score: 0.002
  115. Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion. JAMA. 1995 Sep 13; 274(10):813-9.
    View in: PubMed
    Score: 0.002
  116. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics. 1995 Jul 01; 28(1):1-14.
    View in: PubMed
    Score: 0.002
  117. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet. 1995 Jan; 4(1):1-8.
    View in: PubMed
    Score: 0.002
  118. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet. 1995 Jan; 56(1):114-22.
    View in: PubMed
    Score: 0.002
  119. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science. 1993 Apr 09; 260(5105):235-8.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.